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Background
AIDS-related Kaposi’s sarcoma (AIDS-KS) is the most
common AIDS-associated malignancy and remains a
significant cause of morbidity and mortality in sub-
Saharan Africa. We describe the determinants of mortal-
ity among patients with AIDS-KS in a comprehensive
HIV care and treatment program in Jos, Nigeria.
Material and methods
We collected epidemiologic, clinical, staging and survival
data for 357 patients with a diagnosis of AIDS-KS enrol-
ling for HIV-care at the Jos University Teaching Hospital.
Patients were staged according to the AIDS Clinical Trials
Group (ACTG) criteria, which are based on the evaluation
of tumor extension (T), CD4+ cell count (I), and patient’s
systemic status (S), stratified by good (0) versus poor (1)
risk. Information on survival was obtained through an
active follow-up on verification of vital status of the
patients. Survival analysis was computed by the Kaplan-
Meier method, and the log-rank test was used to test the
difference between subgroups.
Results
During the period of the study (2004-2008), there were
197 women (55.2%) and 160 (44.8%) men with AIDS-
related Kaposi Sarcoma. Their mean age was 37±8 years
and the median follow-up was 15 months (1-49 months).
The median CD4+ and viral load were 107cells/mm³ and
58,561copies/ml respectively at baseline. Only 42 (11.8%)
were on HAART at KS diagnosis, however all patients
were commenced on HAART in line with existing
national guidelines subsequently. 262(74.4%) had poor
immune system status (I1: CD4+<200cells/mm
3), 77.5%
had widespread tumor extension (T1) and 80.2% had sys-
temic disease (S1). Poor immune system (I1) status (AOR
2.07, CI 1.25-3.42, p=0.002) and presence of systemic dis-
ease (S1) (AOR 2.10, CI 1.03-4.28, p=0.004) were inde-
pendently associated with mortality.
Regarding ACTG classification, the 4-year survival rate
was 67% for I0 vs 46% for I1 (p=0.05), 58% for S0 vs
49% for S1 (p=0.41), 60% for T0 vs 46% for T1 (p=0.19).
Conclusion
Poor immune status and systemic disease are indepen-
dent predictors of mortality in patients with AIDS-KS in
Nigeria.
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